Wenguang He

1.2k total citations · 1 hit paper
26 papers, 743 citations indexed

About

Wenguang He is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Wenguang He has authored 26 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Wenguang He's work include Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Wenguang He is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Wenguang He collaborates with scholars based in China, Canada and Netherlands. Wenguang He's co-authors include Yunxiuxiu Xu, Ruomei Wang, Yibiao Ye, Yinjun He, Guosheng Wu, Weixiang Zhong, Xile Zhou, Weiqin Jiang, Hanju Hua and Yanshan Li and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and British Journal of Pharmacology.

In The Last Decade

Wenguang He

25 papers receiving 740 citations

Hit Papers

Exhausted CD8+T Cells in the Tumor Immune Microenvironmen... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
    2021 225 citations Weiqin Jiang, Yinjun He et al. Frontiers in Immunology profile →

Peers

Wenguang He
Wenjun Mou China
Biancamaria Ricci Italy
Andrea Pelosi Italy
Zhangyan Guo China
Guangbo Zhang China
Yixiao Gong United States
Luigi Ombrato United Kingdom
Wan-Li Liu China
Taro Tobo Japan
Carol M. Amato United States
Wenjun Mou China
Wenguang He
Citations per year, relative to Wenguang He Wenguang He (= 1×) peers Wenjun Mou

Countries citing papers authored by Wenguang He

Since Specialization
Citations

This map shows the geographic impact of Wenguang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenguang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenguang He more than expected).

Fields of papers citing papers by Wenguang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenguang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenguang He. The network helps show where Wenguang He may publish in the future.

Co-authorship network of co-authors of Wenguang He

This figure shows the co-authorship network connecting the top 25 collaborators of Wenguang He. A scholar is included among the top collaborators of Wenguang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenguang He. Wenguang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yinjun, Xiang Zhang, Wenguang He, et al.. (2025). Optimization of Immunotherapy Strategies Based on Spatiotemporal Heterogeneity of Tumour‐Associated Tissue‐Resident Memory T Cells. Immunology. 175(2). 123–133. 1 indexed citations
2.
Jiang, Beibei, Xiang Zhang, Wenguang He, et al.. (2025). The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer. The Oncologist. 30(6). 3 indexed citations
3.
Zhang, Xiang, Yinjun He, Wenguang He, et al.. (2024). Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 16. 2669771–2669771.
4.
Han, Yang, et al.. (2024). Paeonol alleviates ox-LDL-induced endothelial cell injury by targeting the heme oxygenase-1/phosphoinositide 3-kinase/protein kinase B pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(1). 591–600. 1 indexed citations
5.
He, Wenguang, et al.. (2024). Case report: Robust response to sintilimab in advanced distal cholangiocarcinoma with PD-L1 expression and DNA damage repair. Frontiers in Pharmacology. 15. 1336699–1336699. 2 indexed citations
6.
Xia, Wei, Dandan Li, Wenguang He, et al.. (2024). Multicenter Evaluation of a Weakly Supervised Deep Learning Model for Lymph Node Diagnosis in Rectal Cancer at MRI. Radiology Artificial Intelligence. 6(2). e230152–e230152. 6 indexed citations
7.
8.
He, Yinjun, Xiang Zhang, Ming Zhu, et al.. (2023). Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer. Journal of Translational Medicine. 21(1). 46–46. 25 indexed citations
9.
Cheng, Xiaofei, et al.. (2023). Immunotherapy as a promising treatment strategy for dmmr colorectal cancer with brain metastasis: a case report. Journal of Cancer Metastasis and Treatment. 2 indexed citations
10.
Jiang, Weiqin, Yinjun He, Wenguang He, et al.. (2023). Metastatic sites and lesion numbers cooperated to predict efficacy of PD‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer. Cancer Medicine. 12(11). 12482–12494. 1 indexed citations
11.
Hua, Hanju, Wenguang He, Nan Chen, et al.. (2023). Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy. Frontiers in Immunology. 13. 974793–974793. 9 indexed citations
12.
Jiang, Weiqin, Yinjun He, Wenguang He, et al.. (2021). Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. Frontiers in Immunology. 11. 622509–622509. 225 indexed citations breakdown →
13.
He, Wenguang, et al.. (2021). HIF-1α Hydroxyprolines Modulate Oxygen-Dependent Protein Stability Via Single VHL Interface With Comparable Effect on Ubiquitination Rate. Journal of Molecular Biology. 433(22). 167244–167244. 17 indexed citations
14.
Qi, Simin, Wei Hu, Dehua Yu, et al.. (2021). Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer. Molecular Therapy — Nucleic Acids. 26. 11–21. 4 indexed citations
15.
Wang, Xiunan, Yan Yang, Dandan Ren, et al.. (2020). JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300‐mediated acetylation of RORγt. British Journal of Pharmacology. 177(13). 2959–2973. 13 indexed citations
16.
Li, Yanshan, Yunxiuxiu Xu, Ruomei Wang, et al.. (2020). Expression of Notch–Hif-1α signaling pathway in liver regeneration of rats. Journal of International Medical Research. 48(9). 15 indexed citations
17.
Zhang, Wei, Ben A. Bailey-Elkin, Robert C. M. Knaap, et al.. (2017). Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants. PLoS Pathogens. 13(5). e1006372–e1006372. 46 indexed citations
18.
Guan, Wenbin, Wenguang He, Meng Qiao, et al.. (2016). Ossifying renal tumor of infancy (ORIT): The clinicopathological and cytogenetic feature of two cases and literature review. Pathology - Research and Practice. 212(11). 1004–1009. 4 indexed citations
19.
Li, Wenhong, Wenguang He, Nan Jiang, et al.. (2014). Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma. PLoS ONE. 9(2). e88796–e88796. 57 indexed citations
20.
Li, Lingling, Yicheng Xie, Guang‐Xian Zhang, et al.. (2013). Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer. BMC Cancer. 13(1). 412–412. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjun Mou Breakdown of academic impact, for papers by Biancamaria Ricci Breakdown of academic impact, for papers by Andrea Pelosi Breakdown of academic impact, for papers by Zhangyan Guo Breakdown of academic impact, for papers by Guangbo Zhang Breakdown of academic impact, for papers by Yixiao Gong Breakdown of academic impact, for papers by Luigi Ombrato Breakdown of academic impact, for papers by Wan-Li Liu Breakdown of academic impact, for papers by Taro Tobo Breakdown of academic impact, for papers by Carol M. Amato
Rankless by CCL
2026